BIO-TECHNE Corp·4/A

Feb 3, 4:38 PM ET

McManus Matthew 4/A

4/A · BIO-TECHNE Corp · Filed Feb 3, 2025

Insider Transaction Report

Form 4/AAmended
Period: 2024-08-15
McManus Matthew
President - Diag & Spatial Bio
Transactions
  • Award

    Performance Restricted Stock Units

    2024-08-15+15,82515,825 total
    Common Stock (15,825 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F2]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file
  • 4
    form4a.xml

    AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES